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Abstract: Recent findings revealed pivotal roles for eosinophils in protection against parasitic
and viral infections, as well as modulation of adaptive immune responses in the gastric mucosa.
However, the known effects of eosinophils within the respiratory tract remain predominantly
pathological, associated with allergy and asthma. Simulating natural respiratory infections in mice,
we examined how efficient and well-adapted pathogens can block eosinophil functions that contribute
to the immune response. Bordetella bronchiseptica, a natural pathogen of the mouse, uses the sigma
factor btrS to regulate expression of mechanisms that interfere with eosinophil recruitment and
function. When btrS is disrupted, immunomodulators are dysregulated, and eosinophils are recruited
to the lungs, suggesting they may contribute to much more efficient generation of adaptive immunity
induced by this mutant. Eosinophil-deficient mice failed to produce pro-inflammatory cytokines, to
recruit lymphocytes, to organize lymphoid aggregates that resemble Bronchus Associated Lymphoid
Tissue (BALT), to generate an effective antibody response, and to clear bacterial infection from the
respiratory tract. Importantly, the failure of eosinophil-deficient mice to produce these lymphoid
aggregates indicates that eosinophils can mediate the generation of an effective lymphoid response
in the lungs. These data demonstrate that efficient respiratory pathogens can block eosinophil
recruitment, to inhibit the generation of robust adaptive immune responses. They also suggest
that some post-infection sequelae involving eosinophils, such as allergy and asthma, might be a
consequence of bacterial mechanisms that manipulate their accumulation and/or function within the
respiratory tract.
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1. Introduction
Eosinophils are well-known to be involved in asthmatic [1–10] and allergic reactions [11–15].
However, the eosinophilic dysregulation that contributes to these disorders does not likely reflect the
authentic evolutionarily conserved roles of these unique cells in maintaining host health [14,16–20].
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Eosinophils are recognized to play crucial roles in immune responses to parasites [16,21–26], as well as in
the maintenance of homeostasis [27–30] and regulation of inflammatory responses in the gastrointestinal
mucosal epithelium [24–32]. In fact, eosinophils have antibacterial [33,34] capabilities themselves,
including the ability to engulf bacteria [35–44], or to form traps [45–47] that physically contain
bacteria, similar to other immune cells, such as neutrophils. However, how eosinophils modulate
adaptive immune responses during bacterial respiratory infections remains not fully understood [48].
Intriguingly, there is a correlation between respiratory infections and increasing risk of asthma
and allergies [49–54], suggesting that eosinophils might be involved in the immune responses to
these infections, and infection-induced dysregulation may contribute to this hyper-responsiveness.
However, if the role(s) of eosinophils in the immune response to infection involves complex interactions
and communication with multiple other immune cells, it/they might be difficult to detect and/or study
in crude models of human pathogens infecting mice. In addition, the more important these cells might
be to a vigorous immune response, the stronger the selective pressure on well-adapted pathogens to
subvert their functions, obscuring our ability to measure and study them.
The Bordetella bronchiseptica–mouse experimental system is particularly useful as a natural
infection model that allows for the detailed study of the interactions between bacteria and host
immune system, each of which can be manipulated both independently and in combination, to probe
and define their molecular-level interactions. Using this powerful experimental system, we recently
discovered a B. bronchiseptica sigma factor (btrS) which is involved in the modulation of host immune
responses, inhibiting T- and B-cell-mediated immunity to allow bacteria to persist indefinitely. In its
absence, the host immune response is much more robust and can completely clear the infection [55].
Importantly, the resulting robust immune response both clears these otherwise lifelong infections and
prevents subsequent infections with B. bronchiseptica or the closely related species B. pertussis [55].
The induced protection is stronger than that induced by vaccination or prior infection with the
wild-type parental strain; this is further evidence of a coordinated immunosuppressive strategy that is
btrS-dependent. This experimental system now allows for an exploration of the improved protective
immunity induced by the mutant, to better understand the immunological mechanisms involved that
are able to better control and clear infection, which has important applications to ongoing efforts to
improve the currently failing pertussis vaccines.
Transcriptomic data of macrophages challenged with B. bronchiseptica (Bb), or a DbtrS mutant
derivative (BbDbtrS), revealed that cytokines associated with eosinophil activation and asthma, such as
IL-25, IL-33, and CXCL10, were suppressed via a btrS-dependent mechanism [55]. We further observed
that btrS mediates the suppression of eosinophil influx to the lungs during B. bronchiseptica infections.
In the absence of btrS, eosinophils are recruited to the respiratory tract in large numbers, and lymphoid
cells aggregate in the lungs. Mice lacking eosinophils were severely defective in the recruitment of T
and B cells and their organization into recognizable lymphoid aggregates, and they were deficient
in the production of IL-17, IL-6, and IL-1b, which are cytokines that are known to be critical for
the clearance of Bordetella spp. [56–64]. Together, these findings reveal that B. bronchiseptica blocks
eosinophil influx via a btrS-dependent mechanism(s), to prevent eosinophil-mediated recruitment
and organization of lymphoid aggregates that resemble BALT and stronger protective immunity.
Altogether, these results suggest that prior difficulties in detecting eosinophil contributions to the
generation of adaptive immunity might be because successful respiratory pathogens have evolved
means to suppress eosinophil functions.
2. Materials and Methods
2.1. Bacterial Strains and Culture Conditions
Bordetella bronchiseptica RB50 wild-type (Bb) and RB50 mutant strain, herein BbDbtrS [55],
were grown on plates of Difco Bordet-Gengou agar (BD, cat. 248200) supplemented with 10% sheep
defibrinated blood and 20µg/mL concentration of streptomycin, as previously described [55,65].
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2.2. Animal Experiments
Wild-type C57BL/6J, Balb/cJ (WT) and Balb/cJ DdblGATA-1 [66] (EO-) mice were obtained
from Jackson Laboratories, Bar Harbor, ME, or our breeding colony (established from Jackson
laboratories mice). Mice were bred and maintained at Paul D. Coverdell Center for Biomedical
and Health Sciences, University of Georgia, GA, (AUP: A2016 02-010-Y2-A3) [55]. All experiments
were carried out in accordance with all institutional guidelines (Bordetella Host Interactions AUP:
A2016 02-010-Y2-A6). Nasal cavity, trachea, lungs, spleen, and blood were collected, post-mortem,
in 1 mL of cold Phosphate-buffered saline (PBS). When tissues were used to enumerate colonies,
collection was performed in beaded tubes. When organs were collected for immunological studies,
they were collected in 15 mL falcon tubes containing sterile PBS.
For pathological studies, mice were euthanized by using CO2, followed by fixation with
Formalin [55,67]. Tissues were subsequently processed and stained with hematoxylin and eosin.
The undersigned board-certified pathologist performed, blindly, all microscopic evaluations of
these hematoxylin and eosin (HE)-stained sections at the Athens Veterinary Diagnostic Laboratory.
Immunohistochemistry was performed as follows. Briefly, the primary antibody used was
non-conjugated polyclonal rabbit anti-CD3 antibody (Dako A0452). The antibody was provided
as a ready-to-use antiserum with staining time of 60 min. The antigen retrieval performed was
heat-induced epitope retrieval, using citrate buffer with a pH of 6.0 (HK086-9K, Biogenex, San Ramon,
CA, USA), for 15 min. Endogenous peroxidase was blocked by using 3% hydrogen peroxide (H312-500,
Fisher Scientific, Fair Lawn, NJ, USA), for 5 min. All other blocking was completed with Power
Block (HK085-5K, Biogenex, San Ramon, CA, USA), for 5 min. Positive tissue controls consisted of
formalin-fixed, paraffin-embedded mouse lymph node. As a negative control, the primary antibody
was eliminated and substituted with Universal Negative Control provided as the immunoglobulin
fraction of serum from non-immunized rabbits. Streptavidin conjugated to horseradish peroxidase
antibody conjugate system (4+HRP, HP604 H, L; Bio Care Medical) in PBS (K1016, Dako, Carpinteria,
CA, USA) for 10 min was used as a detection for the secondary antibody. The substrate–chromogen
system used was 3, 3′ diaminobenzidine (DAB; K3466, Dako, Carpinteria, CA, USA), for 12 min.
The tissue sections were counterstained with Gills #2 hematoxylin, followed by bluing, and then they
were dehydrated in ethyl alcohol levels of 70%, 95%, and 100%, cleared in xylene, and mounted with
xylene-based mounting medium.
2.3. Enzyme-Linked Immunosorbent Assays and Cytokine Assays
Serum samples were utilized to evaluate antibody titers. Then, 96-well microtiter plates (Costar)
were coated with heat-killed Bb∆btrS as previously reported [55]. SureBlue (SeraCare, cat. 5120-0076)
was added to start the reaction, which was terminated with HCl, after three minutes. The plates were
read at an OD of 450 nm. The titer was determined to be the reciprocal of the lowest dilution in which
an OD of 0.1 was obtained.
To asses IL-1β, TNF-α, IL-17, and IL-6 expression, the collected trachea was homogenized,
using the bead mill. Following homogenization, the tubes were centrifuged for 5 min, at 14,000 rpm
and 4 ◦C, and the supernatant was collected to quantify levels of cytokines via commercially available
ELISA kits (DuoSet ELISA system, R&D Systems).
2.4. Flow Cytometry
Spleen and lungs were processed and stained as previously described [55,68–70]. Numbers of
live cells were enumerated with Countess II (Thermo Fisher) with trypan blue stain. Two million
live cells were seeded in each well, for staining (see Table 1, below). The acquisition of the data was
performed by using BD-LSR II (Becton Dickinson), and the analysis was completed with FlowJo 10.0,
following standard gating strategy. Statistical significance was calculated by using two-way ANOVA
in GraphPrism.
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Table 1. List of antibodies for flow cytometry.
Flow Cytometry Antibodies
Fluorochrome Target Clone Vendor Ref
APC-Cy7 GR1 RB6–8C5 Biolegend 108–424
PE CD11b M1/70 Tonbo 50–0112–U100
PerCP F4/80 BM8 Biolegend 123,126
APC SiglecF S17007L Biolegend 155,508
BV510 CD193 CCR3 BD Biosciences 747,820
PerCP CD19 6D5 Biolegend 115,532
PE CD90.2 53–2.1 Biolegend 140,308
AF488 CD4 GK1.5 Biolegend 100,423
BV510 CD8 53–6.7 BD Biosciences 563,068
We used fluorescence minus one (FMO), unstained control, and compensation beads controls in
each one of our experiments. Dilutions were titrated prior to the assay, to guarantee no unspecific stains.
Our gating strategy included first selecting the single cells population, using Forward scatter
height versus forward scatter area density plot for doublet exclusion (FSCH/FSC-A); then, with the
selected population, we performed a doublet discrimination (SSCW/SSC-H); and, finally, we cleaned the
sidescatter by using SSC-A/SSC-H. We then followed the manufacture’s recommendation to specifically
select viable cells, using Ghost dye (Tonbo, 13-0871-T500). From there, we continued our grating
strategy by following the criteria shown in Table 2.
Table 2. Gating strategy.
+ + +
Eosinophils CD11b CD193 SiglecF
B cells CD11b CD19
CD4 CD11b CD90.2 CD4
CD8 CD11b CD90.2 CD8
2.5. Ethics Statement
This study was carried out in strict accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the
Institutional Animal Care and Use Committee at the University of Georgia, Athens (A2016 02-010-Y2-A3
Bordetella-Host Interactions and A2016 07-006-Y2-A5 Breeding protocol). All animals were anesthetized
with 5% isoflurane and euthanized by using carbon dioxide inhalation, followed by cervical dislocation,
to minimize animal suffering. Animals were handled by following institutional guidelines, in keeping
with full accreditation from the Association for Assessment and Accreditation of Laboratory Animal
Care International.
2.6. Statistical Analysis
All results were graphed in GraphPrism (version 8.0.2), and statistical significance was calculated
by using two-way ANOVA. A power analysis was used (G-Power 3) to compare the immunological
response and colonization, and we utilized at least 6 mice per group (and experiments were performed
in triplicate), at alpha 0.05 and power of 80%.
For all of our experiments, we used both genders (male and female), to account for
gender variability.
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3. Results
3.1. Splenic eosinophils Numbers Increase in Response to B. bronchiseptica
Our prior transcriptomic analysis of macrophages exposed to wild-type Bb or BbDbtrS strains
revealed that Bb suppresses the production of IL-33, IL-25, CXCL10, and other factors associated
with inflammation [55]. Based on these results, we hypothesized that btrS mediates the modulation
of inflammatory cell recruitment and activation in the respiratory tract [55]. To investigate this
possibility, we inoculated C57BL/6J mice with the wild-type strain of Bb, and, at different time points,
we enumerated bacterial and immune cell numbers in the lungs and spleen. Bb numbers rose rapidly,
as expected, and this infection increased eosinophil (CD11b+CD193+SiglecF+ cells) numbers in the
spleen, slightly, by day three, and over three-fold by day seven (Figure 1A), coinciding with the peak of
bacterial numbers (Figure 1B). However, eosinophil numbers were only slightly increased in the lungs
(Figure 1C), despite the large numbers of bacteria there (Figure 1B). The large increase in spleen but
not at the site of infection suggested respiratory infection results in a substantial increase in eosinophil
numbers produced in the spleen, but Bb somehow interferes with their recruitment to the lungs.
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3.2. Bordetella bronchiseptica Blocks Eosinophil Recruitment to the Lungs
Since the BbDbtrS mutant failed to suppress the macrophage inflammatory response, based
on our previously published transcriptomic data, and induced much more effective protective
immunity in vivo [55], we tested the hypothesis that Bb blocks eosinophil recruitment to the lungs
by a btrS-mediated mechanism. Consistent with this hypothesis, mice challenged with BbDbtrS had
substantially more eosinophil numbers in both the spleen (Figure 1A) and lungs (Figure 1C), coinciding
with the peak of infection (Figure 1B). Moreover, the numbers of eosinophils at the site of infection
remained high until BbDbtrS was cleared from the lungs (Figure 1B,C), suggesting that Bb uses a
BtrS-dependent mechanism to block eosinophils’ recruitment (Figure 1C). Furthermore, the timing
of their recruitment, which peaked just before BbDbtrS numbers began to decline, implicated these
eosinophils as potential mediators of the robust immunity induced by the BbDbtrS strain.
3.3. Eosinophil-Deficient Mice Fail to Clear Respiratory Infection
To investigate the contribution of eosinophils to the robust immune response to BbDbtrS,
we compared infections in wild-type (Balb/cJ) and eosinophil-deficient (∆dblGATA-1) mice, which
fail to produce mature eosinophils and are one of the most commonly used models for the study
of eosinophilic functions and biology [66]. Wild-type (WT) mice were able to rapidly clear bacteria
from the upper and lower respiratory tract (Figure 2). In contrast, eosinophil-deficient mice (EO-)
more slowly cleared bacteria from the lower respiratory tract (Figure 2C) and failed to clear bacteria
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from the upper respiratory tract, even after 169 days (Figure 2A,B). Interestingly, when WT and EO-
mice were challenged with wild-type Bb, no differences in the colonization dynamics were detected
(Figure S1A), revealing that Bb blocks both eosinophil recruitment and function via btrS-mediated
mechanism. When EO- mice were challenged with BbDbtrS, the colonization timescale resembled
that caused by wild-type Bb (Figure S1B), indicating that, in the absence of eosinophils, btrS plays a
small role in infection. Overall, these results suggest that Bb blocks eosinophil-mediated generation of
protective immunity via a btrS-dependent mechanism.
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Figure 2. Eosinophil-deficient mice failed to clear bacterial infection from the respiratory tract.
Balb/cJ—WT (wild-type) (red) or DdblGATA-1—EO- (eosinophil-deficient) (green) mice were
intranasally challenged with 50 µL of PBS containing 5 × 105 BbDbtrS. At different days, mice
were euthanized, a d colonies were enumerated in the nasal cavity (A), trachea (B), or lungs (C).
The graphs show the average and SEM. ** p < 0.01, **** p < 0.0001, using two-way ANOVA test. This
experiment as conducted multiple inde endent times, to compensate for possible effects of times of
the year a d sponta eous allergic reactions on osinophils counts. = 22.
3.4. Eosinophils Contribute to Cytokine Secretion in Respiratory Mucosal Surfaces
The failure of the eosinophil-deficient mice to clear BbDbtrS infection suggests that eosinophils
contribute to the generation of protective adaptive immunity within the respiratory tract, analogous
to their role in gastric mucosal immunity, also demonstrated in these mice [71]. To explore how
eosinophils augment the robust adaptive immunity to BbDbtrS, we inoculated this strain into WT and
EO- mice and assessed cytokine levels in the trachea, which is rich in mucosal surfaces [28], and, where
such differences can be measured [26], IL-1b and IL-17, key cytokines for the clearance of Bordetella spp.
infections [57,64,72–74], were increased in WT mice at day seven post-challenge (Figure 3A,B). IL-6 was
increased in WT mice at day 14 post-infection, while, in EO- mice, these differences were not detectable
(Figure 3C). These results suggest that the milieu of signals instigated by the highly immunogenic
BbDbtrS strain are substantially missing in the absence of eosinophils, implicating eosinophils in the
cytokine response that shapes the generation of adaptive immunity.
3.5. Eosinophils Mediate Lymphocyte Recruitment to the Lungs
The markedly different cytokine profiles produced by these two different mouse strains suggest
that B- and T-cell recruitment might be modulated by eosinophils. It is known that eosinophils can
present viral antigen to CD8 T cells [48], and there is evidence that they also modulate B cells [75,76].
Moreover, the modulatory effect of eosinophils in B and T cells can be observed even in naïve uninfected
mice [48,75,77]. We have previously reported that the T- and B-cell numbers in the lungs of WT mice
were at least twice as high on day 14 post-challenge with BbDbtrS as in WT mice challenged with
Bb [55]. To examine the effect of eosinophils on the substantial T- and B-cell recruitment induced by
BbDbtrS, we inoculated this strain into WT or EO- mice. T-cell numbers were substantially higher
in WT Balb/c mice by day 14 post-infection, as in C57BL/6J mice (Figure 1), while in EO- mice, there
were smaller numbers that increased modestly with infection but were still substantially lower than
uninfected WT (Figure 4A). B-cell numbers were recruited to the lungs by BbDbtrS in even higher
numbers in WT Balb/c mice, but their numbers were unchanged by this severe infection in EO- mice
(Figure 4B). While in the wild-type mice the numbers of B cells nearly tripled by 14 days post-challenge,
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in eosinophil-deficient mice, B-cell numbers remained much lower and did not change measurably in
response to 14 days of infection. This substantial defect in the recruitment of B cells to the lungs of EO-
mice suggests that eosinophils are critical to the robust local B-cell response to this infection.Microorganisms 2020, 8, x FOR PEER REVIEW 7 of 16 
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Figure 4. Eosinophil-deficient ice faile to recruit lymphocytes to the lung. WT or EO- mic were
intranasally challenged with 50 µL of PBS, or PBS containing 5 × 105 BbDbtrS. Mice were euthanized at
day 14 post-infection, to enumerate T (A) and B (B) cell populations. WT indicates Balb/c, and EO-
stands for DdblGATA-1 mice. BbDbtrS indicates if intranasal challenge has been (+) or not (-) performed.
The graphs show the average and SEM. * p < 0.05, **** p < 0.001, using two-way ANOVA. This experiment
was conducted multiple independent times, to control for possible effects of times of the year and
spontaneous allergic reactions. n = 20.
3.6. Eosinophils Are Required for an Efficient Antibody Response
To investigate whether the defect of B cells’ numbers in the lungs of EO- mice is reflective of
systemic differences in B-cell response, we measured anti-BbDbtrS antibody titers in the serum of
wild-type and EO- mice, at various days after inoculation with BbDbtrS. In WT mice, BbDbtrS-specific
antibody titers increased to over 1000 by day 21 and over 4000 by day 28. In stark contrast, EO- mice
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barely generated detectable antibody titers by day 21, and values had only risen to about 100 by day 28,
even though the bacterial numbers, reflecting antigen load, were sustained at much higher numbers
than in WT mice (Figure 5A,B). These data indicate that eosinophils play a crucial role in systemic
antibody production in response to respiratory infection, which can explain the delay in clearance of
the bacterial infection from the respiratory tract.
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Figure 5. Eosinophil-deficient mice failed to generate protective antibodies. WT or EO mice were
intranasally challenged with 50 µL of PBS or PBS containing 5 × 105 BbDbtrS, in two independent
experiments. At different days, mice were anized, and serum was collected to perform ELISA, to
evaluate anti-Bb antibody titers (results are the average of two independent assays in triplicate). IgG1
(A) and IgG2a (B) were evaluated. The data are shown as average and SEM; * p < 0.05 and ** p < 0.01,
using Student t-test. n = 6.
3.7. Eosinophils Contribute to an Organized Local Immune Response
We anticipated that failure to generate a robust adaptive response would lead to differences in
the lung inflammatory responses. In order to investigate how the local inflammatory and cellular
response might be affected by eosinophils, we challenged WT and EO- mice to examine changes in the
induced lung pathology. Wild-type mice developed organized inflammatory cell-mediated responses
(Figure 6A), with formation of lymphoid aggregates assembled into recognizable BALT. EO- mice had
less lymphoid activity, despite having higher bacterial number, and formed only indistinct structure,
characterized by fewer, smaller, and less organized accumulations of macrophages and neutrophils,
with few lymphocytes (Figure 6B), suggesting defective generation of localized immune response in
these eosinophil-deficient mice. These distinct responses indicate that eosinophils can regulate both
the inflammatory response and the generation of protective immunity by mediating the formation of
lymphoid aggregates resembling BALT, in response to local respiratory infections, analogous to their
role in the gastric mucosa [28].
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4. Discussion
We recently demonstrated that btrS-mediated mechanisms contribute to B. bronchiseptica’s ability
to suppress immunity to persist in the respiratory tract [55]. Here we demonstrate that btrS-mediated
mechanisms suppress the accumulation and function of eosinophils, identifying these cells as targets
of immunosuppression. More detailed examination of eosinophil-deficient mice revealed profound
defects in aspects of the stimulation and organization of functional protective adaptive immunity.
EO- mice were defective in the ability to produce key cytokines, recruit lymphocytes, and organize
them in aggregates in which local adaptive immunity can be generated. In addition to revealing
important new roles for eosinophils, this work suggests that targeted disruption of eosinophil functions
can suppress the local immune response in the respiratory tract. Other persistent commensals and
pathogens are likely to have evolved similar strategies, potentially explaining why these important roles
of eosinophils were not previously readily observed; successful respiratory pathogens can block them.
The particulars of the role(s) of eosinophils in adaptive immunity in the respiratory tract are
intriguing. One hypothesis is that, during bacterial respiratory infections, eosinophils facilitate
immune homeostasis and adaptive immunity [78] by influencing the cytokine milieu and immune
signaling pathways [79–84]. This would generate a strong selective pressure on bacteria to evolve
and develop mechanisms to block eosinophilic functions. Excitingly, we report a new role for
eosinophils which involves the generation of robust protective immunity against bacterial respiratory
infections, apparently mediated by the formation of lymphoid aggregates near the site of infection.
A better understanding of the molecular mechanisms by which eosinophils mediate the recruitment,
organization and maturation of lymphoid aggregates can provide novel targets for therapeutics and
potentially augment vaccines inducing local mucosal immunity.
The defects of EO- mice in cytokine production, lymphocytes recruitment, and lymphocyte
organization into aggregates suggest eosinophils may be important in the efficient generation of
local lymphoid structures in which lymphocytes are activated and develop. Eosinophils possess
Toll-Like Receptors [85–89], indicating that they harbor receptors to respond to infections and trigger
the required immune response. This response could be relatively direct; for example, eosinophils
might directly present antigens to T cells, as they do during parasitic [24,25,90], viral [48], and allergic
reactions [91], indicating they have the required machinery to respond to bacterial infections and
activate the subsequent inflammatory response and augment the following adaptive responses.
Bordetella spp. provide an exceptional natural-host experimental system in mice, where aspects of
bacterial–host interactions can be probed at the molecular level. However, Bordetella spp. are not the only
pathogens well-adapted to manipulate respiratory immunity to persist. The revelation that eosinophils
can mediate effective protective immunity leads to the expectation that successful respiratory pathogens
have been under strong selection for the ability to disrupt these functions. It appears likely that one or
more human pathogens that were previously common can similarly suppress eosinophil functions,
and that their partial or complete control (via medicines, vaccines, and “hygiene”) would likely leave
eosinophils tending to be excessively activated, potentially contributing to the upsurge in asthma and
allergy. The mechanism by which B. bronchiseptica interferes with eosinophil recruitment and function
could be an important target for the development of novel therapeutics against eosinophil-mediated
pathologies like asthma and allergy. Conversely, understanding how eosinophils contribute to the
generation of protective immunity could also facilitate the development of more effective vaccines
inducing local mucosal immunity and therapies against a variety of respiratory pathogens.
5. Conclusions
It is well-established that Bordetella spp. sense details of the local host environment [65,92–95]
and carefully and coordinately regulate multiple mechanisms to modulate host immune responses,
suppressing the generation of robust immunity [55,92,96]. The type 3 and type 6 secretion
systems [97,98], adenylate cyclase toxin [99–101], pertussis toxin [102,103], and other
immunomodulators can affect immune cells in vitro and in vivo, and disrupting their carefully
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choreographed expression can lead to much more robust adaptive immunity [55]. Our previous work
revealed how classical Bordetella spp. (B. pertussis, B. parapertussis, and B. bronchiseptica) similarly
respond to blood and serum [65], and one of the genes that increase expression levels in response
to blood and serum is btrS (sigE type sigma factor). When btrS is knocked out, B. bronchiseptica
fails to dampen the host response and induces much stronger protective immunity [55]. Here we
reveal that btrS is involved in the blockage of eosinophil recruitment to the lungs, reducing adaptive
immune responses and promoting persistence. Moreover, our data indicate that eosinophils mediate
cytokine production and B-cell responses to respiratory infections, providing new roles for these cells
in the generation of protective respiratory immunity. Excitingly, our work associates eosinophils with
the generation of lymphoid aggregates, suggesting that a better understanding of the underlying
mechanisms can provide targets for therapeutics against a broad spectrum of diseases. There is
also a positive correlation between Bordetella spp. infections and the development of asthma and
allergy [104–111], highlighting the clinical significance of these findings and suggesting there may be
more implications in this complex interaction.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2607/8/11/1808/s1.
Figure S1: Colonization levels in the lungs of Balb/c and DdblGATA-1 mice following infection with Bb and BbDbtrS.
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